{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:58:19Z","timestamp":1775069899398,"version":"3.50.1"},"reference-count":47,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2005,12]]},"abstract":"<jats:p>BACKGROUND: Plasma HIV RNA levels reflect systemic viral replication but in CNS it may occur relatively independent of systemic infection, yet clinical application of CSF HIV-1 RNA levels is less clear. OBJECTIVE: to compare CSF and plasma HIV-1 RNA levels of patients with different opportunistic neurological diseases to those without neurological disease, as well as to correlate these levels with the outcome of the disease and use of HAART. METHOD: 97 patients who had lumbar puncture for routine work up of suspected neurological diseases, were divided in 2 groups: without neurological disease (23) and with neurological disease (74). NASBA was used for plasma and CSF HIV RNA. RESULTS: Median CSF viral load was higher in toxoplasmic encephalitis, cryptococcal meningitis, HIV dementia and neurological diseases without a defined etiology when compared to patients without neurological disease. There was no difference between plasma viral load in patients with and without neurological diseases. Median viral load was higher in plasma and CSF among patients who died when compared to those successfully treated. CSF and plasma viral load were lower in patients with opportunistic diseases on HAART than without HAART. CONCLUSION: CSF viral load was higher in patients with any neurological disease, but this difference was not present in plasma viral load, suggesting that neurological disease influences more the CSF than plasma compartments. Notwithstanding different neurological diseases were not possible to be diferentiated by the levels of CSF HIV-1.<\/jats:p>","DOI":"10.1590\/s0004-282x2005000600001","type":"journal-article","created":{"date-parts":[[2006,1,10]],"date-time":"2006-01-10T18:36:52Z","timestamp":1136918212000},"page":"907-913","source":"Crossref","is-referenced-by-count":20,"title":["HIV-1 RNA levels in cerebrospinal fluid and plasma and their correlation with opportunistic neurological diseases in a Brazilian AIDS reference hospital"],"prefix":"10.1590","volume":"63","author":[{"given":"Paulo P.","family":"Christo","sequence":"first","affiliation":[{"name":"FHEMIG, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirceu B.","family":"Greco","sequence":"additional","affiliation":[{"name":"Federal University of Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agdemir W.","family":"Aleixo","sequence":"additional","affiliation":[{"name":"Federal University of Minas Gerais, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Livramento","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/00007611-198706000-00004","article-title":"Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome","volume":"80","author":"Berger JR","year":"1987","journal-title":"South Med J","ISSN":"https:\/\/id.crossref.org\/issn\/0038-4348","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00002030-199714000-00010","article-title":"Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy","volume":"11","author":"Brodt HR","year":"1997","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1750-3639.2003.tb00010.x","article-title":"HIV-1 persistence, viral reservoir, and the central nervous system in the HAART era","volume":"13","author":"Lambotte O","year":"2003","journal-title":"Brain Pathol","ISSN":"https:\/\/id.crossref.org\/issn\/1015-6305","issn-type":"print"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/13550280390194073","article-title":"Pathogenesis of human immunodeficiency virus-induced neurological disease","volume":"9","author":"Albright AV","year":"2003","journal-title":"J Neurovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1355-0284","issn-type":"print"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00126334-200210010-00007","article-title":"HIV-1 related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy","volume":"31","author":"Neuenberg JK","year":"2002","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.56.2.257","article-title":"HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998","volume":"56","author":"Sackor N","year":"2001","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/ana.10827","article-title":"Changing incidence of central nervous system disease in the EuroSIDA cohort","volume":"55","author":"d\u2019Armino MA","year":"2004","journal-title":"Ann Neurol."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1080\/13550280290101094","article-title":"The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy","author":"Sackor N","year":"2002","journal-title":"J Neurovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1355-0284","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1212\/WNL.38.1.9","article-title":"Early penetration of the blood-brain barrier by HIV","volume":"38","author":"Resnick L","year":"1988","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.42.9.1736","article-title":"Early viral brain invasion in iatrogenic human immunodeficiency virus infection","volume":"42","author":"Davis LE","year":"1992","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/00002030-200209270-00003","article-title":"Factors influencing virological response to antiretroviral drugs in cerebrospinal fluid of advanced HIV-1 infected patients","volume":"16","author":"Antinori A","year":"2002","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/313810","article-title":"Neurological symptoms during primary human immunodeficiency v\u00edrus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid","volume":"30","author":"Tambussi G","year":"2000","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/JCM.30.7.1768-1771.1992","article-title":"Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals","volume":"30","author":"Chiodi F","year":"1992","journal-title":"J Clin Microbiol","ISSN":"https:\/\/id.crossref.org\/issn\/0095-1137","issn-type":"print"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00002030-198804000-00003","article-title":"HIV isolation from cerebrospinal fluid in relation in immunological deficiency and neurological symptoms","volume":"2","author":"Sonnerborg AB","year":"1988","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-125-4-199608150-00001","article-title":"Clinical and epidemiologic features of primary HIV infection","volume":"125","author":"Schacker T","year":"1996","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1086\/517379","article-title":"High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid of patients with lymphocytic meningitis","volume":"177","author":"Morris L","year":"1998","journal-title":"J Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archneur.59.6.923","article-title":"Progression to neurological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA","volume":"59","author":"Ellis RJ","year":"2002","journal-title":"Arch Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0003-9942","issn-type":"print"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1126\/science.8096089","article-title":"High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR","volume":"259","author":"Piatak M","year":"1993","journal-title":"Science","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time","volume":"271","author":"Perelson AS","year":"1996","journal-title":"Science","ISSN":"https:\/\/id.crossref.org\/issn\/0036-8075","issn-type":"print"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4 + lymphocytes as prognostic markers of HIV-1 infection","volume":"126","author":"Mellors JW","year":"1997","journal-title":"Ann Intern Med","ISSN":"https:\/\/id.crossref.org\/issn\/0003-4819","issn-type":"print"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/13550280390194109","article-title":"Human immunodeficiency virus-associated dementia: an evolving disease","volume":"9","author":"McArthur JC","year":"2003","journal-title":"J Neurovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1355-0284","issn-type":"print"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1212\/01.WNL.0000058768.73358.1A","article-title":"Changes in CSF and plasma HIV-1 RNA and cognition after starting potent antiretroviral therapy","volume":"60","author":"Marra CM","year":"2003","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1212\/WNL.41.6.778","article-title":"Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1(HIV-1) infection","volume":"41","year":"1991","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1086\/520301","article-title":"The level of human immunodeficiency virus (HIV) type I RNA in cerebrospinal fluid as a marker of HIV encephalitis","volume":"26","author":"Bossi P","year":"1998","journal-title":"Clin Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/1058-4838","issn-type":"print"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/514001","article-title":"Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage","volume":"175","author":"Brew BJ","year":"1997","journal-title":"J Infect Dis","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410420504","article-title":"Relationship between human immunodeficiency virus-associated dementia and viral in cerebrospinal fluid and brain","volume":"42","author":"McArthur JC","year":"1997","journal-title":"Ann Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.410420503","article-title":"Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome","volume":"42","author":"Ellis RJ","year":"1997","journal-title":"Ann Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/0364-5134","issn-type":"print"},{"key":"ref28","first-page":"S95","article-title":"Molecular analysis of cerebrospinal fluid: potential for the study of HIV-1 infection of central nervous system","volume":"6:","author":"Cinque P","year":"2000","journal-title":"J Neurovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1355-0284","issn-type":"print"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1212\/01.WNL.0000145763.68284.15","article-title":"Evaluation of HIV RNA and markes of immune activation as predictors of HIV-associated dementia","volume":"63","author":"Sevigny JJ","year":"2004","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0140-6736(92)90142-P","article-title":"Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans","volume":"339","author":"Pettoello-Mantovani M","year":"1992","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref31","first-page":"727","article-title":"Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus","volume":"7","author":"Lederman MM","year":"1994","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00042560-199512000-00005","article-title":"Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurological abnormalities","volume":"10","author":"Conrad AJ","year":"1995","journal-title":"J Acquir Immune Def Syndr Hum Retroviral"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF01716081","article-title":"HIV-1 replication in the plasma and cerebrospinal fluid","volume":"24","author":"Lafeuillade A","year":"1996","journal-title":"Infection","ISSN":"https:\/\/id.crossref.org\/issn\/0173-2129","issn-type":"print"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/13550289809113485","article-title":"CSF, plasma viral load and HIV associated dementia","volume":"4","author":"Robertson K","year":"1998","journal-title":"J Neurovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1355-0284","issn-type":"print"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/00002030-200305230-00008","article-title":"Suppression of cerebrospinal fluid HIV burden in antiretroviral naive patients on a potent four-drug antiretoviral regimen","volume":"17","author":"Polis MA","year":"2003","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref36","first-page":"669","article-title":"Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive","volume":"6","author":"Stankoff B","year":"1999","journal-title":"Eur J Neurol","ISSN":"https:\/\/id.crossref.org\/issn\/1351-5101","issn-type":"print"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00126334-199908010-00003","article-title":"Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection","volume":"21","author":"Gissl\u00e9n M","year":"1999","journal-title":"J Acquir Immune Defic Syndr","ISSN":"https:\/\/id.crossref.org\/issn\/0894-9255","issn-type":"print"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1212\/WNL.59.3.342","article-title":"Correlates of independent HIV-1 replication in the CNS and of its control by retrovirals","volume":"59","author":"De Luca A","year":"2002","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1097\/00002030-199815000-00005","article-title":"Antiretroviral drugs and the central nervous system","volume":"12","author":"Enting RH","year":"1998","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2165\/00023210-200216090-00002","article-title":"Clinical implications of CNS penetration of antiretroviral drugs","volume":"16","author":"Wynn HE","year":"2002","journal-title":"CNS drugs","ISSN":"https:\/\/id.crossref.org\/issn\/1172-7047","issn-type":"print"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/WNL.54.4.927","article-title":"Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources","volume":"54","author":"Ellis RJ","year":"2000","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.57.3.542","article-title":"CSF antiretroviral drug penetrance and the treatment of HIV-associated psychomotor slowing","volume":"57","author":"Sackor N","year":"2001","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/infdis\/175.2.434","article-title":"The effect of cerebrospinal fluid HIV RNA levels after initiation of zidovudine or didanosine","volume":"175","author":"Gissl\u00e9n M","year":"1997","journal-title":"J Infet Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00002030-199906180-00008","article-title":"Time course of cerebrospinal fluid responses to antiretroviral therapy: evidence for variable compartmentalization of infection","volume":"13","author":"Staprans S","year":"1999","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref45","first-page":"535","article-title":"Longitudinal comparison of HIV-1 RNA burden in plasma and cerebrospinal fluid in two patients starting triple combination antiretroviral therapy","volume":"12","author":"Itimovici E","year":"1998","journal-title":"AIDS","ISSN":"https:\/\/id.crossref.org\/issn\/0269-9370","issn-type":"print"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(98)07333-4","article-title":"Cerebrospinal fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine","volume":"351","author":"Foudraine NA","year":"1998","journal-title":"Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0099-5355","issn-type":"print"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00042560-199903010-00007","article-title":"HIV infection of the central nervous system is characterized bu rapid turnover of viral RNA in cerebrospinal fluid","volume":"20","author":"Eggers CC","year":"1999","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol","ISSN":"https:\/\/id.crossref.org\/issn\/1077-9450","issn-type":"print"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v63n4\/a01v63n4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T01:46:58Z","timestamp":1586656018000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2005000600001&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0004-282X2005000600001"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2005000600001","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}